youtube_live
Q3 2026 earnings
See resultschevron_right
EPRX:TSE
Eupraxia Pharmaceuticals Inc
CA$ ११.११
arrow_downward
-२.९७%(-०.३४) 1D
नोभेम्बर १२, १६:००:०० GMT-५ · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EPRX...
Open
CA$ ११.२१
High
CA$ ११.४३
Low
CA$ १०.८७
Mkt. cap
७४.७१ करोड
Avg. vol.
१.०२ लाख
Volume
७०.४६ हजार
52-wk high
CA$ १३.०८
52-wk low
CA$ ७.८५
EPS
-CA$ १.३४
Beta
१.२५
Shares outstanding
६.५९ करोड
No. of employees
४९
Open
CA$ ११.२१
High
CA$ ११.४३
Low
CA$ १०.८७
Mkt. cap
७४.७१ करोड
Avg. vol.
१.०२ लाख
Volume
७०.४६ हजार
52-wk high
CA$ १३.०८
52-wk low
CA$ ७.८५
EPS
-CA$ १.३४
Beta
१.२५
Shares outstanding
६.५९ करोड
No. of employees
४९
News stories
From web sources and news partners
kalkine.ca
·
७ घण्टा पहिले
TSX-listed small-cap stock Eupraxia Pharmaceuticals (TSX:EPRX) draws fresh attention as completion of phase 2b enrollment has brought a major clinical catalyst into view for december
TradingView
·
१ दिन पहिले
Eupraxia Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $16.1, Implies 111% Upside
Investing News Network
·
१ दिन पहिले
Eupraxia Pharmaceuticals Reports Third Quarter 2026 Financial Results
About Eupraxia Pharmaceuticals Inc
CEO-
Employees४९
Founded२०११
Headquartersभिक्टोरिया, ब्रिटिश कोलम्बिया, क्यानाडा
SectorHealth Care
Industry-
Websiteeupraxiapharma.com